New Alzheimer’s Drugs: Breakthroughs, Trials, and Cost Barriers
Roche is advancing clinical trials for Trontinemab, a novel Alzheimer’s antibody. Following long-term data presented at the AAIC 2026 conference, the drug aims to slow Alzheimer’s symptoms, though its potential ... Read More